Cargando…
Update on Salvage Options in Relapsed/Refractory Hodgkin Lymphoma after Autotransplant
Despite a high clinical success, relapse in Hodgkin lymphoma occurs in 10–30% of cases and 5–10% patients are nonresponsive to initial chemotherapy. The standard management of these patients includes high-dose chemotherapy followed by autologous stem cell transplant. However, 50% of patients ultimat...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003874/ https://www.ncbi.nlm.nih.gov/pubmed/25006506 http://dx.doi.org/10.1155/2014/605691 |